[Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].
The purpose of our experience was to determine the efficacy of haloperidol decanoate during the treatment of chronic psychotic in-patients. So we included, in an open study, 30 patients hospitalized in the Esquirol and Magnan Departments of the National Hospital of Mental Health "Dr. Braulio A. Moyano". As a result of this study, we have observed that to the already known properties of this drug, it may be added, because of its new depot formulation, the following advantages: a) it replaces effectively the daily intake of neuroleptics; b) it allows the reduction of the dose of oral neuroleptics as well as the number of drugs combination; c) it diminishes the incidence of extrapyramidal symptoms, allowing the reduction of the dose or the interruption of antiparkinsonian drugs; d) it facilitates the nurse's labor; e) it allows the physician to be sure of the fulfillment of his prescription.
Marchant
N
N
Caruso
S
S
Cuervo
L
L
Brizuela
A
A
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006220:Haloperidol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007297:Inpatients; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents; C033563:haloperidol decanoate; D006220:Haloperidol
Evaluación de la eficacia del haloperidol decanoato en el tratamiento de pacientes psicóticas crónicas hospitalizadas.